Evidence map›Paper›PMID 36451526›Full record

ArticleMedical science monitor : international medical journal of experimental and clinical research2022

Clinical Outcomes of Extracranial Carotid Artery-Related Stroke Eligible for Mechanical Reperfusion on Top of Per-Guidelines Thrombolytic Therapy: Analysis from a 6-Month Consecutive Patient Sample in 2 Centers.

Karolina Dzierwa, Magdalena Knapik, Łukasz Tekieli, Adam Mazurek, Małgorzata Urbańczyk-Zawadzka, Artur Klecha, Tomasz Kowalczyk, Teresa Koźmik, Łukasz Wiewiórka, Paweł Banyś and 5 more

Open access · hybridAbstract read
In one paragraph

Article in Medical science monitor : international medical journal of experimental and clinical research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 3 institutions in 2 countries.

Karolina DzierwaCardiovascular Imaging Laboratory, John Paul II Hospital, Crakow, Poland.
Magdalena KnapikThrombectomy-Capable Stroke Centre, John Paul II Hospital, Cracow, Poland.
Łukasz TekieliThrombectomy-Capable Stroke Centre, John Paul II Hospital, Cracow, Poland.
Adam MazurekThrombectomy-Capable Stroke Centre, John Paul II Hospital, Cracow, Poland.
Małgorzata Urbańczyk-ZawadzkaThrombectomy-Capable Stroke Centre, John Paul II Hospital, Cracow, Poland.
Artur KlechaDepartment of of Cardiology, Podhalanski Multispecialty Regional Hospital, Nowy Targ, Poland.
Tomasz KowalczykDepartment of of Cardiology, Podhalanski Multispecialty Regional Hospital, Nowy Targ, Poland.
Teresa KoźmikDepartment of of Cardiology, Podhalanski Multispecialty Regional Hospital, Nowy Targ, Poland.
Łukasz WiewiórkaThrombectomy-Capable Stroke Centre, John Paul II Hospital, Cracow, Poland.ORCID 0000-0001-9967-0212
Paweł BanyśDepartment of of Radiology, John Paul II Hospital, Cracow, Poland.
Ewa WęglarzThrombectomy-Capable Stroke Centre, John Paul II Hospital, Cracow, Poland.
Justyna StefaniakDepartment of of Bioinformatics and Telemedicine, Jagiellonian University Medical College, Cracow, Poland.
Rafał T NizankowskiAccreditation Council, National Centre for Healthcare Quality Assessment, Cracow, Poland.
Iris Q GrunwaldUniversity of Dundee Chair of Neuroradiology and Department of Radiology, Ninewells Hospital, Dundee, Scotland, United Kingdom.
Piotr MusiałekThrombectomy-Capable Stroke Centre, John Paul II Hospital, Cracow, Poland.
John Paul II Hospital · PLJagiellonian University · PLUniversity of Dundee · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND Systemic intravenous thrombolysis and mechanical thrombectomy (MT) are guideline-recommended reperfusion therapies in large-vessel-occlusion ischemic stroke. However, for acute ischemic stroke of extracranial carotid artery origin (AIS-CA) there have been no specific trials, resulting in a data gap. MATERIAL AND METHODS We evaluated referral/treatment pathways, serial imaging, and neurologic 90-day outcomes in consecutive patients, presenting in a real-life series in 2 stroke centers over a period of 6 months, with AIS-CA eligible for emergency mechanical reperfusion (EMR) on top of thrombolysis as per guideline criteria. RESULTS Of 30 EMR-eligible patients (33.3% in-window for thrombolysis and thrombolysed, 73.3% male, age 39-87 years, median Alberta Stroke Program Early Computed Tomography Score (ASPECTS) 10, pre-stroke mRS 0-1 in all, tandem lesions 26.7%), 20 (66.7%) were EMR-referred (60% - endovascular, 6.7% - surgery referrals). Only 40% received EMR, nearly exclusively in stroke centers with carotid artery stenting (CAS) expertise (100% eligible patient acceptance rate, 100% treatment delivery involving CAS±MT with culprit lesion sequestration using micronet-covered stents). The emergency surgery rate was 0%. Baseline clinical and imaging characteristics did not differ between EMR-treated and EMR-untreated patients. Ninety-day neurologic status was profoundly better in EMR-treated patients: mRS 0-2 (91.7% vs 0%; P<0.001); mRS 3-5 (8.3% vs 88.9%; P<0.001), mRS 6 (0% vs 11.1%; P<0.001). CONCLUSIONS In a real-life AIS-CA setting, the referral rate of EMR-eligible patients for EMR was low, and the treatment rate was even lower. AIS-CA revascularization was delivered predominantly in stroke thrombectomy-capable cardioangiology centers, resulting in overwhelmingly superior patient outcome. Large vessel occlusion stroke referral and management pathways should involve centers with proximal-protected CAS expertise. AIS-CA, irrespective of any thrombolysis administration, is a hyperacute cerebral emergency and EMR-eligible patients should be immediately referred for mechanical reperfusion.

Indexed as

Carotid StenosisIschemic StrokeStrokeAdultAgedAged, 80 and overCarotid Artery, CommonFemaleHumansMaleMiddle AgedReperfusionStentsThrombolytic Therapy

Identifiers

PMID36451526
PMCPMC9724447
OpenAlexW4308730312

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.